Founded with a mission to revolutionize synthetic biology, Think Bioscience focuses on designing and assembling superior medicines using living systems. The company's vision is to harness the natural efficiency of cells as chemical processors to create innovative, life-saving treatments. Think Bioscience's core product is its unique platform that programs cells to develop new medicines, targeting prevailing challenges in the pharmaceutical industry.
Think Bioscience has attracted notable investors and industry leaders who recognize the potential of its groundbreaking approach. The company has achieved significant milestones in developing its platform and has garnered attention through various publications and scientific contributions. Overall, Think Bioscience is making a substantial impact by pushing the boundaries of synthetic biology to improve medical outcomes.